Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIN: Single-dose Indomethacin in Extremely Preterm Infants
NCT06572917Phase 2Not yet recruiting
- Sponsor
- University of British Columbia
- Start
- Nov 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of indomethacin in Intraventricular hemorrhage (IVH), sponsored by University of British Columbia. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
indomethacin
03
Conditions
Intraventricular hemorrhage (IVH)
Beyond the preview
Go deeper on NCT06572917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06572917.